ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2025
Emerging insights into primary ciliary dyskinesia-associated hydrocephalus: a scoping review.
Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrocephalus, a condition caused by fluid buildup in the brain, is now recognized as a possible complication of primary ciliary dyskinesia (PCD)-a rare genetic disorder that affects the movement of tiny, hair-like structures called motile cilia. This review brings together current knowledge about the disease's causes, symptoms, and treatments. Specific gene mutations like MCIDAS, DNAH5, CCNO, and IFT46 are key factors, as they disrupt normal cilia movement and fluid flow. Other structural problems, such as narrowed brain passages or overproduction of brain fluid, can worsen the condition. Patients often experience symptoms ranging from developmental delays in infants to headaches and vision issues in older individuals. Because symptoms can overlap with other conditions, early brain imaging and genetic testing are essential. While treatment currently focuses on symptom control, new research may lead to more targeted, gene-based therapies.
Indexed as
Identifiers
40996446What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.